Mustang Bio
MBIO • NASDAQ
Mustang Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Manuel Litchman, with a market cap of $5.5M.
CEOManuel Litchman
Next Earnings
Upcoming earnings announcement for Mustang Bio
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Mustang Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.07 | — | - | — |  10-K |
| Nov 7, 2025 | Q3 2025 | -$0.07 | — | - | — | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.19 | — | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.05 | — | - | — | 10-Q |
| Mar 28, 2025 | Q4 2024 | -$0.94Est: -$8.00 | +88.3% | - | — | 10-K |
| Nov 8, 2024 | Q3 2024 | -$2.00Est: -$6.50 | +69.2% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$17.50Est: -$44.00 | +60.2% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$23.00Est: -$43.50 | +47.1% | - | — | 10-Q |
| Mar 11, 2024 | Q4 2023 | -$35.50Est: -$66.50 | +46.6% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$61.50Est: -$55.50 | -10.8% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$100.00Est: -$90.50 | -10.5% | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$103.00Est: -$150.50 | +31.6% | - | — | — |